
-
Sudan war drains life from once-thriving island in capital's heart
-
Trump trade war casts pall in China's southern export heartland
-
Ukraine's Sumy prepares to bury victims of 'bloody Sunday'
-
Iraq sandstorm closes airports, puts 3,700 people in hospital
-
French prisons targeted with arson, gunfire: ministry
-
Pandemic treaty talks inch towards deal
-
Employee dead, client critical after Paris cryotherapy session goes wrong
-
Howe will only return to Newcastle dugout when '100 percent' ready
-
Journalist recalls night Mario Vargas Llosa punched Gabriel Garcia Marquez
-
Sudan marks two years of war with no end in sight
-
Vance urges Europe not to be US 'vassal'
-
China tells airlines to suspend Boeing jet deliveries: report
-
Stocks rise as stability returns, autos surge on exemption hope
-
Harvard sees $2.2bn funding freeze after defying Trump
-
'Tough' Singapore election expected for non-Lee leader
-
Japan orders Google to cease alleged antitrust violation
-
Stocks rise as stability returns, autos lifted by exemption hope
-
Malawi's debt crisis deepens as aid cuts hurt
-
Danish brewer adds AI 'colleagues' to human team
-
USAID cuts rip through African health care systems
-
Arsenal target Champions League glory to save season
-
Kane and Bayern need killer instinct with home final at stake
-
Mbappe leading Real Madrid comeback charge against Arsenal
-
S. Korea plans extra $4.9 bn help for chips amid US tariff anxiety
-
Xi's Vietnam trip aiming to 'screw' US, says Trump
-
Iran's top diplomat to visit Russia after US nuclear talks
-
China accuses US spies of Asian Winter Games cyberattacks
-
Cambodia genocide denial law open to abuse, say critics
-
Holocaust remembrance and Gaza collide in Brussels schools
-
The miracle babies who survived Ravensbruck
-
Asian stocks mixed as stability returns, autos lifted by exemption hope
-
Disarming Lebanon's Hezbollah no longer inconceivable: analysts
-
London hosts talks to find 'pathway' to end Sudan war
-
Harvey Weinstein New York retrial for sex crimes to begin
-
Meta news ban intensifying Canadians' legacy media break
-
All Black wing Tele'a announces Japan switch
-
Chinese EV battery giant CATL posts 33% surge in Q1 profit
-
US grounds helicopter company behind fatal New York tour
-
China's economy likely grew 5.1% in Q1 on export surge: AFP poll
-
S. Korea govt plans $4.9 bn more help for semiconductors as US tariff risk bites
-
Harvard sees $2.2 billion in funding frozen after defying Trump
-
Israel demands hostage release for Gaza ceasefire: Hamas
-
Baylink Biosciences To Highlight New Preclinical Data At The American Association For Cancer Research (AACR) Annual Meeting
-
Elvictor Group Issues 2024 Annual Report
-
Guardian Metal Resources PLC - Significant Gallium Potential Identified
-
Birkenstock Announces Fiscal Second Quarter 2025 (Ended March 31, 2025) Results Date and Conference Call
-
Meridian Drills Into Shallow High-Grade Cu-Au-Zn & Ag Massive to Semi-Massive Sulphides on the Open Western Limit of Santa Helena
-
The DEA Is Defying Supreme Court Axon in MMJ's Cannabis Case - Is DEA a rogue agency?
-
Formation Metals Deepak Varshney to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2025 to Discuss the N2 Gold Property with a Historical 877,000 oz Gold Resource
-
GECC Reports Fiscal 2025 Q2 Financial Results

Japan drugmaker reports two more deaths in supplement scare
A Japanese drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more deaths potentially related to its tablets.
Last week, Kobayashi Pharmaceutical recalled three supplement brands -- "Beni Koji Choleste Help" and two others -- after customer complaints of kidney problems.
The over-the-counter products contain an ingredient called red yeast rice, or "beni koji", which is supposed to help lower cholesterol.
Thursday's announcement brings the total number of deaths under investigation by the company and health ministry to four, with more than 100 other people hospitalised.
"We were told yesterday by a bereaved family that a person who had been using Choleste Help had passed away due to kidney disease," the drugmaker said in a statement.
It added it had been told separately that another person who had used Choleste Help in recent years had died.
"We are in the process of confirming the facts and causal relationships in both of these cases," the statement said.
"However, we decided to make this report public from the viewpoint of prompt disclosure."
Medical studies describe red yeast rice as an alternative to statins for lowering high cholesterol, but also warn of a risk of organ damage depending on its chemical make-up.
Kobayashi Pharmaceutical sells a wide range of health products marketed through television adverts in Japan.
The Osaka-based company says it has also supplied red yeast rice to around 50 other firms in Japan and two in Taiwan.
Government spokesman Yoshimasa Hayashi said Thursday that authorities were doing "their utmost to ensure food safety, including identifying the substance that caused the health harm and how it became present in the product".
The government has ordered various health-food makers to review their products, while informing foreign countries about the issue through Japan's embassies, he said.
Dozens of Japanese firms that used beni koji provided by Kobayashi Pharmaceutical have also separately announced recalls.
The affected products include health tablets as well as a rose-coloured sparkling sake, salad dressing, bread and miso paste used in many traditional dishes.
Kobayashi Pharmaceutical has said analysis had found a possibility that the products contained "ingredients we had not intended to include".
But it said it did not find any citrinin produced by red yeast rice, which is toxic and can damage the kidneys.
C.Garcia--AMWN